Skip to main content
. Author manuscript; available in PMC: 2012 Nov 1.
Published in final edited form as: Semin Cancer Biol. 2011 Sep 18;21(5):335–346. doi: 10.1016/j.semcancer.2011.09.008

Fig. 2.

Fig. 2

Targeting B-cell activation. The B-cell receptor signaling pathway is initiated through phosphorylation of co-receptors Igα (CD79a) and Igβ (CD79b), recruiting the tyrosine kinase SYK. In turn, SYK phosphorylates several downstream kinases including BTK and PI3Kδ. BAFF receptor signaling involves cross-talk with BCR and also results in activation of NFκB. Targeted inhibitors used in clinical trials are shown.